Supernus Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Supernus Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $6.7M | 215k | 31.18 |
| 2024-06-30 | $2.3M | 87k | 26.75 |
| 2024-03-31 | $2.8M | 81k | 34.11 |
| 2023-12-31 | $3.0M | 104k | 28.94 |
| 2023-09-30 | $2.2M | 81k | 27.57 |
| 2023-06-30 | $1.7M | 56k | 30.06 |
| 2023-03-31 | $630k | 17k | 36.23 |
| 2022-12-31 | $480k | 14k | 35.67 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management